Online citations, reference lists, and bibliographies.

ACVIM Consensus Statement: Support For Rational Administration Of Gastrointestinal Protectants To Dogs And Cats

Stanley L Marks, Peter Hendrik Kook, Mark G Papich, M Katherine Tolbert, Michael D. Willard
Published 2018 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
The gastrointestinal (GI) mucosal barrier is continuously exposed to noxious toxins, reactive oxygen species, microbes, and drugs, leading to the development of inflammatory, erosive, and ultimately ulcerative lesions. This report offers a consensus opinion on the rational administration of GI protectants to dogs and cats, with an emphasis on proton pump inhibitors (PPIs), histamine type‐2 receptor antagonists (H2RAs), misoprostol, and sucralfate. These medications decrease gastric acidity or promote mucosal protective mechanisms, transforming the management of dyspepsia, peptic ulceration, and gastroesophageal reflux disease. In contrast to guidelines that have been established in people for the optimal treatment of gastroduodenal ulcers and gastroesophageal reflux disease, effective clinical dosages of antisecretory drugs have not been well established in the dog and cat to date. Similar to the situation in human medicine, practice of inappropriate prescription of acid suppressants is also commonplace in veterinary medicine. This report challenges the dogma and clinical practice of administering GI protectants for the routine management of gastritis, pancreatitis, hepatic disease, and renal disease in dogs and cats lacking additional risk factors for ulceration or concerns for GI bleeding. Judicious use of acid suppressants is warranted considering recent studies that have documented adverse effects of long‐term supplementation of PPIs in people and animals.
This paper references
10.1016/0002-9343(91)90463-8
Sucralfate therapy and reflux esophagitis: an overview.
Roy C. Orlando (1991)
10.3109/00365528509089662
Sucralfate and alginate/antacid in reflux esophagitis.
Seppo Laitinen (1985)
10.1111/jvim.12461
Wireless Ambulatory Esophageal pH Monitoring in Dogs with Clinical Signs Interpreted as Gastroesophageal Reflux
P. Kook (2014)
10.1111/apt.12318
Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients.
Rami Sweis (2013)
10.1111/j.1939-1676.2009.0454.x
Efficacy of omeprazole versus high-dose famotidine for prevention of exercise-induced gastritis in racing Alaskan sled dogs.
Katherine K. Williamson (2010)
10.1111/j.1365-2982.2012.01888.x
PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis.
P W Weijenborg (2012)
Effects of atropine, acepromazine, meperidine, and xylazine on gastroesophageal sphincter pressure in the dog.
D. R. Strombeck (1985)
10.1016/0016-5085(78)90352-9
Effect of acid and pepsin on blood coagulation and platelet aggregation
F. Green (1978)
10.1111/j.1939-1676.2000.tb01496.x
Gastric mucosal lesions in dogs with acute intervertebral disc disease: characterization and effects of omeprazole or misoprostol.
Reto Neiger (2000)
10.3748/wjg.v21.i1.139
Pharmacological therapy used in the elimination of Helicobacter pylori infection: a review.
Ariolana A Dos Santos (2015)
10.5326/0390523
Packed red blood cell transfusions in dogs with gastrointestinal hemorrhage: 55 cases (1999-2001).
Jennifer E. Waldrop (2003)
10.1159/000028367
Animal Pharmacology of Reversible Antagonism of the Gastric Acid Pump, Compared to Standard Antisecretory Principles
W. Kromer (2000)
10.2460/javma.229.10.1601
Influence of halothane, isoflurane, and sevoflurane on gastroesophageal reflux during anesthesia in dogs.
D. Wilson (2006)
10.1111/j.1365-2036.2007.03407.x
Systematic review: Proton pump inhibitor-associated acute interstitial nephritis.
F. Sierra (2007)
10.3109/00365521.2015.1009157
Upper gastrointestinal physiology and diseases
H. Waldum (2015)
10.1024/0036-7281/a000186
[Severe gastrointestinal bleeding secondary to lornoxicam in the dog].
Peter Hendrik Kook (2011)
Temporary elevation of pancreatic lysosomal enzymes, as a result of the omeprazole-induced peripancreatic inflammation in male Wistar rats.
Franciszek Burdan (2000)
10.1016/0002-9343(91)90460-F
Healing of erosive esophagitis with sucralfate and cimetidine: influence of pretreatment lower esophageal sphincter pressure and serum pepsinogen I levels.
Emilio Ros (1991)
Mechanisms of action of sucralfate.
Renpei Nagashima (1981)
The protective effects of sucralfate and ranitidine in foals experimentally intoxicated with phenylbutazone.
R. Geor (1989)
10.2147/DHPS.S4334
Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors
Alaa Rostom (2009)
10.1111/jvim.12555
Efficacy of Intravenous Administration of Combined Acid Suppressants in Healthy Dogs
M.K. Tolbert (2015)
10.2460/javma.250.5.530
Continuous radiotelemetric monitoring of intragastric pH in a dog with peptic ulceration.
Michael B Lane (2017)
10.1136/gut.2005.064691
Acid reflux event detection using the Bravo wireless versus the Slimline catheter pH systems: why are the numbers so different?
John E. Pandolfino (2005)
10.1111/jvim.14807
Evaluation of Gastric pH and Serum Gastrin Concentrations in Cats with Chronic Kidney Disease
M Katherine Tolbert (2017)
10.1111/1751-2980.12206
Prevalence and risk factors for clinically significant upper gastrointestinal bleeding in patients with severe acute pancreatitis.
Xian Bao Zhan (2015)
10.1046/j.1440-1746.2003.03041.x
Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subjects without Helicobacter pylori infection.
Y. Komazawa (2003)
10.1111/j.1365-2036.2009.03979.x
Clinical trial: the effect and timing of food on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR, a novel Dual Delayed Release formulation of a proton pump inhibitor--evidence for dosing flexibility.
Ronald Duane Lee (2009)
10.2460/ajvr.77.8.818
High-resolution manometric evaluation of the effects of cisapride on the esophagus during administration of solid and liquid boluses in awake healthy dogs.
Tarini Ullal (2016)
10.1042/cs078012p
Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin.
Jeffrey T. L. Smith (1990)
10.1016/0016-5085(93)90344-C
Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis.
Regis R. Lamberts (1993)
10.1002/jps.21602
Fed and fasted gastric pH and gastric residence time in conscious beagle dogs.
Kazuko Sagawa (2009)
10.1038/ajg.2011.474
Proton Pump Inhibitors vs. Histamine 2 Receptor Antagonists for Stress-Related Mucosal Bleeding Prophylaxis in Critically Ill Patients: A Meta-Analysis
Alan N Barkun (2012)
10.1111/j.1748-5827.1998.tb03613.x
Feline chronic renal failure: calcium homeostasis in 80 cases diagnosed between 1992 and 1995.
P. Barber (1998)
10.1345/aph.1R071
Evaluation of Potential Interactions between Mycophenolic Acid Derivatives and Proton Pump Inhibitors
Steven Gabardi (2012)
10.1016/j.cgh.2012.12.011
Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis.
Wai-Kit Lo (2013)
10.1016/J.YASU.2013.02.004
Current management of the Zollinger-Ellison syndrome.
G. Krampitz (2013)
Safety experience with sucralfate in Japan.
Akira Ishimori (1981)
Stress ulceration prevention in live E. coli sepsis in cats
S Arvidsson (1985)
10.1177/0091270002239700
Famotidine disposition in children and adolescents with chronic renal insufficiency.
Holly D. Maples (2003)
Gastroduodenal ulceration in dogs. Retrospective study of 43 cases and literature review.
Michael Stanton (1989)
10.1046/j.1365-2036.1997.00257.x
Review article: the pharmacological inhibition of gastric acid secretion--tolerance and rebound.
A. Sandvik (1997)
10.1111/vec.12434
Prevalence and risk factors for development of hemorrhagic gastro-intestinal disease in veterinary intensive care units in the United Kingdom.
James W. Swann (2016)
Detection of esophageal ulcerations with technetium-99m albumin sucralfate.
John S. Goff (1986)
10.1038/290159a0
Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase
Erik Fellenius (1981)
10.1111/j.1476-4431.2011.00680.x
A review of stress-related mucosal disease.
Andrea A Monnig (2011)
10.1023/A:1016353705970
Comparison of Canine and Human Gastrointestinal Physiology
Jennifer Boehm Dressman (2004)
10.2460/javma.244.1.78
Endovascular evaluation and treatment of intrahepatic portosystemic shunts in dogs: 100 cases (2001-2011).
Chick W Weisse (2014)
10.3945/ajcn.114.097394
Is achlorhydria a cause of iron deficiency anemia?
Andrea L Betesh (2015)
10.1007/s12328-011-0208-y
Proton pump inhibitors: use, misuse and concerns about long-term therapy
T. P. Rakesh (2011)
Efficacy of misoprostol in prevention of gastric hemorrhage in dogs treated with high doses of methylprednisolone sodium succinate.
C. Rohrer (1999)
[Therapeutic possibilities in the management of gastrointestinal bleeding in thrombocytopenic patients].
Mihály Gurzó (1994)
10.4238/2015.July.3.25
Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis.
Hu Xu (2015)
10.2460/ajvr.2005.66.386
Effects of preanesthetic administration of morphine on gastroesophageal reflux and regurgitation during anesthesia in dogs.
Deborah V. Wilson (2005)
Effects of dexamethasone and surgical hypotension on the stomach of dogs: clinical, endoscopic, and pathologic evaluations.
Sorjonen Dc (1983)
10.1111/j.1476-4431.2011.00680.x
A review of stress-related mucosal disease
Andrea A. Monnig Dvm (2011)
Benign esophageal stricture in the dog and cat: a retrospective study of 20 cases.
K. Adamama-Moraitou (2002)
10.1111/j.1572-0241.2000.01701.x
Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration
Leonard Lachman (2000)
10.1007/BF01798367
The treatment of gastric ulcer with antisecretory drugs
C. Howden (2005)
10.4292/wjgpt.v6.i4.127
Helicobacter pylori: Effect of coexisting diseases and update on treatment regimens.
Shen-Shong Chang (2015)
An endoscopic study comparing gastroprotection by prostaglandin E2, misoprostol and cimetidine against multiple doses of aspirin in dogs
MJ Holroyde (1986)
10.1097/00042737-200105000-00025
Proton pump inhibitors and their drug interactions: an evidence-based approach.
Lauren B. Gerson (2001)
10.4254/wjh.v8.i4.231
Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.
Mihajlo Gjeorgjievski (2016)
10.1016/0002-9343(91)90462-7
Reflux esophagitis therapy: sucralfate versus ranitidine in a double blind multicenter trial.
Cedric G. Bremner (1991)
10.1046/j.1440-1746.2000.02055.x
Effect of intragastric pH on control of peptic ulcer bleeding.
Yingjia Li (2000)
10.1007/s10620-013-2725-7
The Role of Food for the Formation and Prevention of Gastrointestinal Lesions Induced by Aspirin in Cats
Hiroshi Satoh (2013)
10.1111/j.1365-2125.1990.tb03679.x
Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects.
Th. Andersson (1990)
10.1111/J.1523-5378.2007.00576.X
Evolution of Helicobacter pylori therapy from a meta-analytical perspective.
J. Gisbert (2007)
Gastric hemorrhage in dogs given high doses of methylprednisolone sodium succinate.
C R Rohrer (1999)
10.1111/j.1939-1676.1995.tb03269.x
The effect of misoprostol on aspirin-induced gastroduodenal lesions in dogs.
Spencer A. Johnston (1995)
10.1111/jvim.14713
Pharmacokinetics and Acid Suppressant Efficacy of Esomeprazole after Intravenous, Oral, and Subcutaneous Administration to Healthy Beagle Dogs
J-H Hwang (2017)
10.1186/s12916-017-0804-x
When is proton pump inhibitor use appropriate?
Rena Yadlapati (2017)
10.1038/ajg.2009.638
Proton Pump Inhibitor and Clopidogrel Interaction: Fact or Fiction?
L. Laine (2010)
10.1001/jama.1989.03430070049022
Ciprofloxacin levels when receiving sucralfate.
J. Yuk (1989)
10.1111/j.1939-1676.1989.tb00863.x
Gastroduodenal Ulceration in Dogs
M. E. Stanton (1989)
10.2460/javma.233.5.729
Clinicopathologic, histologic, and toxicologic findings in 70 cats inadvertently exposed to pet food contaminated with melamine and cyanuric acid.
R. Cianciolo (2008)
10.1136/vr.91.19.441
Peptic ulceration in the dog: a clinico-pathological study
M. E.-A. Murray (1972)
10.1111/sdi.12301
Evidence-based review of gastrointestinal bleeding in the chronic kidney disease patient.
Richard S Kalman (2015)
10.1016/j.drudis.2009.03.014
Proton pump inhibitors: actions and reactions.
James M Mullin (2009)
10.1111/jvp.12165
The effect of sucralfate tablets vs. suspension on oral doxycycline absorption in dogs.
Kate KuKanich (2015)
10.1111/jvim.14704
Prevalence of Gastroesophageal Reflux in Cats During Anesthesia and Effect of Omeprazole on Gastric pH
R. Suescun Garcia (2017)
10.1046/j.1440-1746.2002.02775.x
Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study.
Yongning Zhou (2002)
10.1001/jama.2013.280490
Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency.
Jameson R. Lam (2013)
10.1080/00365510600873894
Achlorhydria is associated with gastric microbial overgrowth and development of cancer: Lessons learned from the gastrin knockout mouse
Lennart J Friis-Hansen (2006)
10.1053/j.gastro.2015.06.043
Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial.
Daniel E Freedberg (2015)
10.5326/15473317-32-5-401
The use of a synthetic prostaglandin E1 analog as a gastric protectant against aspirin-induced hemorrhage in the dog.
T. S. Bowersox (1996)
10.4166/KJG.2012.60.6.362
[Effect of proton pump inhibitor in patients with acute pancreatitis - pilot study].
Jeong Hwan Yoo (2012)
10.1681/ASN.2015121377
Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.
Yan Xie (2016)
10.1152/ajpgi.1992.263.4.G551
Diaphragmatic contribution to gastroesophageal competence and reflux in dogs.
Carl J. Martin (1992)
10.1002/jps.23159
Gastric pH and gastric residence time in fasted and fed conscious beagle dogs using the Bravo pH system.
Kelly M. Mahar (2012)
10.1111/j.1939-1676.2010.0651.x
Efficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogs.
Katherine Tolbert (2011)
10.1111/jvim.14615
Repeated Famotidine Administration Results in a Diminished Effect on Intragastric pH in Dogs
M Katherine Tolbert (2017)
10.1002/jhm.1901
Inappropriate prescribing of proton pump inhibitors in hospitalized patients.
Mark Reid (2012)
10.1038/clpt.2011.222
Unveiling the mysteries of clopidogrel metabolism and efficacy.
Laurent Bonello (2011)
10.1097/MPH.0000000000000292
Severe Hemorrhage in Chinese Children With Immune Thrombocytopenia
F. Zhou (2015)
10.1111/apt.13007
Helicobacter-negative gastritis: a distinct entity unrelated to Helicobacter pylori infection.
R M Genta (2015)
10.1016/j.lfs.2010.09.008
Effects of pantoprazole in experimental acute pancreatitis.
T. Hackert (2010)
10.2460/ajvr.2005.66.425
Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs.
Alexa M E Bersenas (2005)
10.1111/jvim.12342
Relationship among Serum Creatinine, Serum Gastrin, Calcium‐phosphorus Product, and Uremic Gastropathy in Cats with Chronic Kidney Disease
S.M. McLeland (2014)
10.1016/j.mayocp.2017.10.022
Proton Pump Inhibitors: Review of Emerging Concerns
Avinash K. Nehra (2018)
10.1016/0002-9343(87)90826-6
Comparison of the effect of sucralfate and ranitidine in reflux esophagitis.
Bernd Simon (1987)
10.1136/bmj.286.6375.1379
Aluminium hydroxide versus sucralfate as a phosphate binder in uraemia.
Albert C. Leung (1983)
Radiotelemetric determination of gastrointestinal pH in four healthy beagles.
Carole A. Youngberg (1985)
Sucralfate: a review of drug tolerance and safety.
Fisher Rs (1981)
10.1111/j.1939-1676.2008.0206.x
Aluminum toxicity following administration of aluminum-based phosphate binders in 2 dogs with renal failure.
G. Segev (2008)
10.1159/000200917
Appropriate acid suppression for the management of gastro-oesophageal reflux disease.
N. J. Bell (1992)
10.1016/0016-5085(85)90128-3
Sucralfate prevents experimental peptic esophagitis in rabbits.
E. Schweitzer (1985)
10.1007/BF01798351
Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis
Gaston Vantrappen (2005)
Use of synthetic prostaglandin E1 (misoprostol) for prevention of aspirin-induced gastroduodenal ulceration in arthritic dogs.
Robert J. Murtaugh (1993)
10.1016/j.maturitas.2014.05.019
Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study.
L Moberg (2014)
Co - prescription of gastroprotec - tive agents and their efficacy in elderly patients taking nonsteroidal anti - inflammatory drugs : a systematic review of observational stud
ME Stanton (2013)
Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use.
Paul N. Maton (1999)
10.1007/BF01309396
Misoprostol preclinical pharmacology
R. F. Bauer (2005)
10.1177/106002808602000726
Effect of Sucralfate on Phenytoin Bioavailability
Tom G. Hall (1986)
10.4318/TJG.2010.0040
The efficiency of sucralfate in corrosive esophagitis: a randomized, prospective study.
Yüksel Gümürdülü (2010)
10.1056/NEJMoa0809171
Cytochrome p-450 polymorphisms and response to clopidogrel.
J. Mega (2009)
10.1371/journal.pone.0128004
Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis
Allison A. Lambert (2015)
10.1128/AAC.34.5.931
Sucralfate significantly reduces ciprofloxacin concentrations in serum.
James C. Garrelts (1990)
10.1016/j.cgh.2006.09.012
Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials.
W. Wang (2007)
Neural control of the release and action of secretin.
William Y. Chey (2003)
10.1002/jor.23221
Hypochlorhydria‐induced calcium malabsorption does not affect fracture healing but increases post‐traumatic bone loss in the intact skeleton
Melanie Haffner-Luntzer (2016)
10.1111/jvim.15076
Effect of sucralfate on gastric permeability in an ex vivo model of stress‐related mucosal disease in dogs
Tracy L Hill (2018)
Clinical evaluation of cimetidine, sucralfate, and misoprostol for prevention of gastrointestinal tract bleeding in dogs undergoing spinal surgery.
Stephen M Hanson (1997)
10.1016/j.gie.2009.03.003
Isolated gastric mucosal hemorrhages in idiopathic thrombocytopenic purpura.
Shyam Dang (2009)
10.1111/j.1939-1676.2012.00929.x
The influence of esomeprazole and cisapride on gastroesophageal reflux during anesthesia in dogs.
A.C. Zacuto (2012)
10.1186/1471-230X-2-17
Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials
Maribel Salas (2002)
10.1046/j.1365-2036.2000.00829.x
Proton pump inhibitors: better acid suppression when taken before a meal than without a meal.
J. Hatlebakk (2000)
10.1016/s0016-5085(19)32433-3
An intestinal disease produced experimentally by a prostaglandin deficiency.
A. Robert (1975)
Gastrointestinal hemorrhage and pancreatitis associated with intervertebral disk diseases in the dog.
Moore Rw (1982)
10.1371/journal.pone.0110057
The Effect of Naturally Occurring Chronic Kidney Disease on the Micro-Structural and Mechanical Properties of Bone
Anna Shipov (2014)
10.5414/CP202396
Comparative effectiveness and tolerability of esomeprazole and omeprazole in gastro-esophageal reflux disease: A systematic review and meta-analysis.
Qian Qi (2015)
10.7326/0003-4819-111-2-179
Sucralfate, intestinal aluminum absorption, and aluminum toxicity in a patient on dialysis.
Jeannette A. Robertson (1989)
Pepsin and the esophagus.
Basil I. Hirschowitz (1999)
10.1016/S0002-9610(05)81193-6
Concentration of refluxed acid and esophageal mucosal injury.
Ross M Bremner (1992)
10.1177/1098612X14563097
Survey of dietary and medication practices of owners of cats with chronic kidney disease
Jessica E Markovich (2015)
10.2746/042516403775696339
Effect of GastroGard and three compounded oral omeprazole preparations on 24 h intragastric pH in gastrically cannulated mature horses.
Alfred M. Merritt (2003)
10.1046/j.1365-2036.2001.01087.x
Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole.
T. Andersson (2001)
10.3109/03639049509026660
Stability of omeprazole solutions at various PH values as determined by high-performance liquid chromatography
M. Mathew (1995)
10.1111/jvim.13796
Effect of Sucralfate on the Relative Bioavailability of Enrofloxacin and Ciprofloxacin in Healthy Fed Dogs
Kate KuKanich (2016)
CLINICAL EVALUATION OF CIMETIDINE, SUCRALFATE, AND MISOPROSTOL FOR PREVENTION OF GASTROINTESTINAL TRACT BLEEDING IN DOGS UNDERGOING SPINAL SURGERY
Hanson Sm (1997)
10.1111/J.1939-1676.2007.TB01936.X
Triple antimicrobial therapy and acid suppression in dogs with chronic vomiting and gastric Helicobacter spp.
Michael S. Leib (2007)
10.1016/S0149-2918(00)80032-6
The proton-pump inhibitors: similarities and differences.
J. Horn (2000)
10.1016/S0016-5085(85)80133-5
Omeprazole: a study of its inhibition of gastric pH and oral pharmacokinetics after morning or evening dosage.
Peter J. Prichard (1985)
10.1097/CCM.0b013e3182758734
Proton Pump Inhibitors Versus Histamine 2 Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients: A Systematic Review and Meta-Analysis*
W. Alhazzani (2013)
10.1111/j.1939-1676.2005.tb02700.x
Histopathologic features of canine uremic gastropathy: a retrospective study.
R. M. Peters (2005)
10.3920/CEP14002
Effect of simulated deployment patrols on gastric mucosa of explosive detection dogs
Michael Scott Davis (2014)
10.1097/00045391-199508000-00006
EFFECTS OF ALUMINUM/MAGNESIUM HYDROXIDE AND CALCIUM CARBONATE ON ESOPHAGEAL AND GASTRIC pH IN SUBJECTS WITH HEARTBURN
Dennis L. Decktor (1995)
10.1016/0016-5085(90)91015-X
Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression.
D. Burget (1990)
10.1111/j.1572-0241.2003.07398.x
Ambulatory Esophageal pH Monitoring Using a Wireless System
J. Pandolfino (2003)
10.3109/0886022X.2015.1057800
Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies
W. Cheungpasitporn (2015)
10.1097/00045391-199506000-00007
Comparative Effects of Liquid Antacids on Esophageal and Gastric pH in Patients with Heartburn.
Dennis L. Decktor (1995)
Sucralfate: a review of drug tolerance and safety.
Robert S. Fisher (1981)
10.1016/j.cgh.2013.05.034
Co-prescription of gastroprotective agents and their efficacy in elderly patients taking nonsteroidal anti-inflammatory drugs: a systematic review of observational studies.
Stephanie Medlock (2013)
The relationship between gastric acid secretion and gastric H+,K+-ATPase activity.
Bjoern Morgan Gabriel Wallmark (1985)
10.1892/0891-6640(2007)21[924:eofftp]2.0.co;2
Efficacy of famotidine for the prevention of exercise-induced gastritis in racing Alaskan sled dogs.
Katherine K. Williamson (2007)
10.1111/j.1939-1676.2006.tb01794.x
Temporal relationship between gastrointestinal protein loss, gastric ulceration or erosion, and strenuous exercise in racing Alaskan sled dogs.
M A Davis (2006)
10.1111/j.1476-4431.2001.tb00076.x
Complications of Methylprednisolone Sodium Succinate Therapy in Dachshunds with Surgically Treated Intervertebral Disc Disease
Amanda K. Boag (2001)
10.1111/j.1939-1676.2003.tb02428.x
Efficacy of omeprazole for the prevention of exercise-induced gastritis in racing Alaskan sled dogs.
Michael Davis (2003)
10.1111/jvp.12340
The effects of clopidogrel and omeprazole on platelet function in normal dogs
Brittany E Thames (2017)
10.1136/vr.100627
Serum gastrin concentrations in dogs with liver disorders
Michal Mazaki-Tovi (2012)
10.1007/s10620-015-3712-y
Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori
Priscila Baptistella Yazbek (2015)
Gastrin concentrations in plasma of cats with chronic renal failure.
Richard E Goldstein (1998)
10.5326/0380176
Spontaneous gastroduodenal perforation in 16 dogs and seven cats (1982-1999).
Laura Hinton (2002)
10.1007/s002689900079
Protection of the Gastroduodenal Mucosa from the Effects of Diclofenac Sodium: Role of Highly Selective Vagotomy and Misoprostol
Athanasios D. Giannoukas (1996)
10.1007/s11626-006-9004-2
Effect of proton pump inhibitor on amylase release from isolated pancreatic acini
Jia Cai (2006)
10.1111/apt.12857
Gaviscon Double Action Liquid (antacid & alginate) is more effective than antacid in controlling post-prandial oesophageal acid exposure in GERD patients: a double-blind crossover study.
Annemijn A. de Ruigh (2014)
10.1111/vcp.12461
Occult gastrointestinal bleeding is a common finding in dogs with chronic kidney disease.
Leandro Zuccolotto Crivellenti (2017)
Frequency of oral famotidine administration determines the development of tolerance in cats
MK Tolbert (2018)
10.1046/j.1365-2036.2001.01011.x
Ambulatory gastric pH monitoring: proper probe placement and normal values.
William K. Fackler (2001)
10.1016/j.cvsm.2013.05.001
Canine cytochrome P-450 pharmacogenetics.
Michael H. Court (2013)
10.1053/j.gastro.2011.06.075
Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.
John L. Wallace (2011)
10.1016/j.mayocp.2014.07.015
Nonsteroidal anti-inflammatory drugs, proton pump inhibitors, and gastrointestinal injury: contrasting interactions in the stomach and small intestine.
W. Marlicz (2014)
10.2460/javma.241.10.1326
Parathyroid hormone concentration in geriatric cats with various degrees of renal function.
Natalie C Finch (2012)
10.1001/jama.296.24.2947
Long-term proton pump inhibitor therapy and risk of hip fracture.
Yu-Xiao Yang (2006)
10.1001/jamaneurol.2015.4791
Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.
Willy Gomm (2016)
10.1111/bcpt.13023
Side Effects of Long‐Term Proton Pump Inhibitor Use: A Review
P. Haastrup (2018)
10.1111/j.1365-2036.1995.tb00347.x
A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group.
M. Robinson (1995)
10.1016/S0016-5085(00)70004-7
Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome.
M. Wolfe (2000)
10.1111/J.1365-2036.1995.TB00777.X
The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease.
R. Hunt (1995)
10.1016/0002-9343(87)90825-4
Clinical efficacy of sucralfate in reflux esophagitis. Comparison with cimetidine.
Guido N. J. Tytgat (1987)
10.1016/S0016-5085(67)80097-0
Comparison of gastric secretion in conscious dogs and cats.
Sverre Emås (1967)
10.1016/0002-9343(87)90827-8
Sucralfate versus alginate/antacid in the treatment of peptic esophagitis.
M. Evreux (1987)
10.1007/s00405-014-3023-5
Efficacy of sucralfate for the treatment of post-tonsillectomy symptoms
Nora Šiupšinskienė (2014)
10.1111/jvim.12580
The Effect of Orally Administered Ranitidine and Once‐Daily or Twice‐Daily Orally Administered Omeprazole on Intragastric pH in Cats
Sanja Sutalo (2015)
10.1016/0022-4804(75)90005-0
Gastrin levels and gastric acid secretion in anephric patients and in patients with chronic and acute renal failure.
H A Falcão (1975)
10.1046/j.1365-2036.2003.01756.x
Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease.
N. Vakil (2003)
10.1136/vr.165.15.436
Spontaneous gastroduodenal perforations in dogs — a retrospective study of 15 cases
M. Cariou (2009)
10.1023/A:1020905224001
Gastric Acid Secretion in the Dog: A Mechanism-Based Pharmacodynamic Model for Histamine Stimulation and Irreversible Inhibition by Omeprazole
Angela Äbelö (2004)
10.1136/gut.40.1.36
Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.
J. Labenz (1997)
10.1016/J.IJGO.2007.09.004
Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects.
O. S. Tang (2007)
10.1136/gut.30.12.1704
Clot lysis by gastric juice: an in vitro study.
S. Patchett (1989)
10.1111/j.1939-1676.2003.tb02449.x
The effect of dosing interval on the efficacy of misoprostol in the prevention of aspirin-induced gastric injury.
D. M. Ward (2003)
10.1136/gutjnl-2014-307595
The stomach in health and disease
R. Hunt (2015)
10.1016/0002-9343(87)90829-1
Comparison of potential cytoprotective action of sucralfate and cimetidine. Studies with experimental feline esophagitis.
S. Clark (1987)
10.2460/javma.228.2.241
Influence of metoclopramide on gastroesophageal reflux in anesthetized dogs
Deborah V. Wilson (2006)
10.1111/j.1365-2710.1991.tb00330.x
Misoprostol--a logical therapeutic approach to gastroduodenal mucosal injury induced by non-steroidal anti-inflammatory drugs?
G. C. Fenn (1991)
10.1111/jvim.13932
A Prospective, Placebo‐Controlled Pilot Evaluation of the Effect of Omeprazole on Serum Calcium, Magnesium, Cobalamin, Gastrin Concentrations, and Bone in Cats
Emily N Gould (2016)
10.1002/j.1875-9114.1989.tb04152.x
The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin.
David E. Nix (1989)
Effect of sucralfate on theophylline absorption in healthy volunteers.
K A Cantral (1988)
Vomiting and diarrhea in a cat colony
Diggs He (1995)
Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs.
J de Graef (1986)
Neural control of the release and action of secretin
Chey Wy (2003)
10.5555/uri:pii:0016508583904420
Inhibition of gastric acid secretion by omeprazole in the dog and rat.
Hakan Sigurd Larsson (1983)
MECHANISM OF ACTION OF SUCRALFATE
R Nagashama (1981)
10.1002/bdd.2510160502
Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals.
T. Kararli (1995)
10.1007/s11095-004-1185-3
pH-Dependent Dissolution in Vitro and Absorption in Vivo of Weakly Basic Drugs: Development of a Canine Model
R. Zhou (2004)
10.1053/gast.1997.v112.pm9178669
Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis.
N. Chiba (1997)
10.2460/ajvr.70.6.787
Effect of gastric ulceration on physiologic responses to exercise in horses.
Jorge Eric Ruiz Nieto (2009)
Upper gastrointestinal bleeding in patients with chronic renal failure: role of vascular ectasia.
Naga P Chalasani (1996)
10.1016/0016-5085(87)91026-2
Mucosal protection by sucralfate and its components in acid-exposed rabbit esophagus.
Roy C. Orlando (1987)
Effects of dexamethasone and surgical hypotension on the stomach of dogs: clinical, endoscopic, and pathologic evaluations.
D. C. Sorjonen (1983)
10.3389/fvets.2018.00079
Omeprazole Minimally Alters the Fecal Microbial Community in Six Cats: A Pilot Study
Sarah M Schmid (2018)
10.1177/106002809102500710
Altered Absorption of Digoxin, Sustained-Release Quinidine, and Warfarin with Sucralfate Administration
Alain Marcel Rey (1991)
Influence of liver upon canine gastric secretion.
William Silen (1963)
Comparison of effects of cimetidine and omeprazole on mechanically created gastric ulceration and on aspirin-induced gastritis in dogs.
Christine C. Jenkins (1991)
Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women
LM Moberg (2014)
10.3109/03602532.2013.765445
Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics
Marilyn N. Martinez (2013)
Colonic perforation in corticosteroid-treated dogs.
James P. Toombs (1986)
10.1080/00498250110035615
Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole
S. Furuta (2001)
10.1016/j.amjgastroenterol.2003.09.053
Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study
P. Miner (2003)
10.1001/jamainternmed.2015.7193
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
Benjamin M. Lazarus (2016)
10.1093/cid/civ432
Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study.
Daniel E Freedberg (2015)
10.1002/pds.4043
Proton pump inhibitor prescribing patterns in the UK: a primary care database study.
Fatmah Othman (2016)
10.1097/CCM.0b013e3181f17adf
Stress ulcer prophylaxis in the new millennium: A systematic review and meta-analysis
P. Marik (2010)
10.1002/(SICI)1098-2299(199606)38:2<73::AID-DDR1>3.0.CO;2-H
Evaluation of gastrointestinal pH and gastric residence time via the Heidelberg radiotelemetry capsule: Pharmaceutical application
P. Mojaverian (1996)
10.1371/journal.pone.0056060
Proton Pump Inhibitor Use in the U.S. Ambulatory Setting, 2002–2009
Stephen Rotman (2013)
10.1111/jvim.12493
Evaluation of the Effect of Orally Administered Acid Suppressants On Intragastric pH in Cats
Sarah Parkinson (2015)
Complications associated with high-dose prednisolone sodium succinate therapy in dogs with neurological injury.
Ledlie Culbert (1998)
10.1111/jvp.12116
Effect of sucralfate on oral minocycline absorption in healthy dogs.
Kate KuKanich (2014)
10.1053/jfms.2001.0148
Gastroduodenal Ulceration in Cats: Eight Cases and a Review of the Literature
Julius M Liptak (2002)
10.3109/00365528809090178
Sucralfate versus placebo in reflux esophagitis. A double-blind multicenter study.
L. Carling (1988)
10.1007/s10620-015-3642-8
The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study
Orlaith B. Kelly (2015)
10.1016/0016-5085(86)90565-2
Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs
Jacques de Graef (1986)
Colonic perforation in corticosteroid-treated dogs.
Toombs Jp (1986)
Pepsin and the esophagus.
Hirschowitz Bi (1999)
10.2460/ajvr.75.4.361
High-resolution manometric evaluation of the effects of cisapride and metoclopramide hydrochloride administered orally on lower esophageal sphincter pressure in awake dogs.
Jennifer Kempf (2014)
10.1016/0014-2999(96)00093-3
Non-adrenergic non-cholinergic neuron stimulation in the cat lower esophageal sphincter.
N. Kortezova (1996)
10.5326/0400455
Postanesthetic esophageal dysfunction in 13 dogs.
D. Wilson (2004)
10.1201/b17857-22
Evolution of the
R. E. Zissell (1998)
10.5555/uri:pii:0016508578903529
Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage.
F. Green (1978)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar